Advisor Group Holdings, Inc. Gilead Sciences, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 271,396 shares of GILD stock, worth $24.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

271,396

Previous 288,082 5.79%

Holding current value

$24.4 Million

Previous $19.8 Million 15.09%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $1.11 Million - $1.4 Million	-16,686 Reduced 5.79%	271,396 $22.7 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $1.58 Million - $1.83 Million	-25,058 Reduced 8.0%	288,082 $19.8 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $28.3 Million - $34.5 Million	-395,116 Reduced 55.79%	313,140 $22.9 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $7.91 Million - $8.97 Million	-107,978 Reduced 13.23%	708,256 $57.4 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $23.6 Million - $25.7 Million	318,848 Added 64.1%	816,234 $61.2 Million
Q2 2023 Aug 21, 2023	SELL	$76.01 - $86.7 $91 Million - $104 Million	-1,197,190 Reduced 70.65%	497,386 $38.3 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $92 Million - $105 Million	1,209,885 Added 249.62%	1,694,576 $131 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $1.89 Million - $2.15 Million	-24,447 Reduced 4.8%	484,691 $40.2 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $3.65 Million - $5.24 Million	58,614 Added 13.01%	509,138 $43.7 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2.07 Million - $2.37 Million	34,839 Added 8.38%	450,524 $27.8 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $2.7 Million - $3.04 Million	46,763 Added 12.68%	415,685 $25.7 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $773,984 - $969,886	13,363 Added 3.76%	368,922 $20.7 Million
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $2.38 Million - $2.57 Million	35,187 Added 10.98%	355,559 $24.8 Million
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $1.22 Million - $1.33 Million	19,169 Added 6.36%	320,372 $22.1 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $1.5 Million - $1.72 Million	25,053 Added 9.07%	301,203 $19.5 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $3.31 Million - $3.78 Million	-58,491 Reduced 17.48%	276,150 $16.1 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $141,029 - $177,319	2,271 Added 0.68%	334,641 $21.1 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $10.6 Million - $12.3 Million	-147,013 Reduced 30.67%	332,370 $25.4 Million
Q1 2020 May 18, 2020	BUY	$62.63 - $80.22 $30 Million - $38.5 Million	479,383 New	479,383 $26 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Gilead Sciences, Inc. Transaction History